Reese Lou 4

4 · Vaxxinity, Inc. · Filed Apr 5, 2023

Form 4

Period: 2023-03-07

DirectorExecutive Chairman

Transactions

Award
Stock Option (right to buy)
2023-03-07+61,607→ 61,607 total
Exercise: $2.29Exp: 2033-03-07→ Class A Common Stock (61,607 underlying)
Award
Stock Option (right to buy)
2023-03-07+620,000→ 620,000 total
Exercise: $2.29Exp: 2033-03-07→ Class A Common Stock (620,000 underlying)
Award
Stock Option (right to buy)
2023-03-07+301,188→ 301,188 total
Exercise: $2.29Exp: 2033-03-07→ Class A Common Stock (301,188 underlying)

Footnotes (3)

[F1]The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options vest in 48 equal monthly installments beginning on March 7, 2023.
[F2]The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options are fully vested upon issuance. This one-time option grant was made in lieu of an annual cash bonus payment to Mr. Reese.
[F3]The options were issued to the Reporting Person pursuant to the Issuer's 2021 Omnibus Incentive Compensation Plan. Such options vest in 12 equal monthly installments beginning on January 1, 2023. The one-time option grant was made in consideration of Mr. Reese waiving his salary for fiscal years 2022 and 2023.

Documents

1 file